APRESAZIDE 25/25 CIBA 139 (Apresazide 25 mg / 25 mg)
Generic Name: hydralazine/hydrochlorothiazide
Pill imprint APRESAZIDE 25/25 CIBA 139 has been identified as Apresazide 25 mg / 25 mg.
Apresazide is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Apresazide 25 mg / 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APRESAZIDE 25/25 CIBA 139 (Apresazide 25 mg / 25 mg)
Apresazide
- Generic Name:
- hydralazine/hydrochlorothiazide
- Imprint:
-
APRESAZIDE 25/25
CIBA 139 - Strength:
- 25 mg / 25 mg
- Color:
- Blue / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
More resources
Apresazide is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
